Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Tirzepatide wins 2 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Mostly mechanism / observational
Verdict
Mostly mechanism / observational
Top outcomes
250-500mg combined EPA+DHA daily for general health; up to 1000mg+ DHA for higher omega-3 status or triglyceride goals
with-meals
Algal DHA oil (or EPA+DHA oil)
Once-weekly subcutaneous injection, started at 2.5 mg and escalated by 2.5 mg every 4 weeks to a maintenance dose of 5, 10, or 15 mg (per the prescribing physician and approved indication)
any
Once-weekly subcutaneous injection (Mounjaro / Zepbound)
4-12 weeks
Weeks at adequate dose
Long term
Weeks to months
Months (dose-escalated over ~20 weeks)
Weeks to months
Mostly during titration
Algal-oil capsules and cooked salmon: nutritionally equivalent sources of docosahexaenoic acid.
J Am Diet Assoc (2008) · Rct · n=32 healthy adults
Both sources raised plasma phospholipid DHA ~80% and erythrocyte DHA ~25%
Bioequivalence of docosahexaenoic acid from different algal oils in capsules and in a DHA-fortified food.
Lipids (2007) · Rct · n=60 (12 per group)
Algal DHA capsules and DHA-fortified food were bioequivalent for DHA delivery
High-fat meals rich in EPA plus DHA compared with DHA only have differential effects on postprandial lipemia and plasma 8-isoprostane F2alpha concentrations relative to a control high-oleic acid meal.
Am J Clin Nutr (2014) · Crossover · n=16 men
Fish oil (EPA+DHA) modestly reduced the postprandial triacylglycerol rise versus control
Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes.
N Engl J Med (2021) · Rct · n=1879
Open-label 40-week phase-3 head-to-head RCT (SURPASS-2) in 1879 patients with type 2 diabetes, tirzepatide 5/10/15 mg vs semaglutide 1 mg
Tirzepatide Once Weekly for the Treatment of Obesity.
N Engl J Med (2022) · Rct · n=2539
72-week phase-3 double-blind RCT (SURMOUNT-1) in 2539 adults with obesity (without diabetes), tirzepatide 5/10/15 mg vs placebo
Tirzepatide as Compared with Semaglutide for the Treatment of Obesity.
N Engl J Med (2025) · Rct · n=751
Phase-3b open-label head-to-head RCT (SURMOUNT-5) in 751 adults with obesity but without diabetes, max-tolerated tirzepatide vs max-tolerated semaglutide
Tirzepatide has a higher evidence score (7.8/10 vs 5.5/10) and wins in 2 of 3 categories.
No known interactions between Algae Oil and Tirzepatide have been documented in our database. However, always consult a healthcare provider before combining supplements.